These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

275 related articles for article (PubMed ID: 22592077)

  • 1. The immunosuppressive factors IL-10, TGF-β, and VEGF do not affect the antigen-presenting function of CD40-activated B cells.
    Shimabukuro-Vornhagen A; Draube A; Liebig TM; Rothe A; Kochanek M; von Bergwelt-Baildon MS
    J Exp Clin Cancer Res; 2012 May; 31(1):47. PubMed ID: 22592077
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic profile of dendritic and T cells in the lymph node of Balb/C mice with breast cancer submitted to dendritic cells immunotherapy.
    da Cunha A; Antoniazi Michelin M; Cândido Murta EF
    Immunol Lett; 2016 Sep; 177():25-37. PubMed ID: 27423825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonreplicating recombinant vaccinia virus expressing CD40 ligand enhances APC capacity to stimulate specific CD4+ and CD8+ T cell responses.
    Feder-Mengus C; Schultz-Thater E; Oertli D; Marti WR; Heberer M; Spagnoli GC; Zajac P
    Hum Gene Ther; 2005 Mar; 16(3):348-60. PubMed ID: 15812230
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous targeting of CD3 on T cells and CD40 on B or dendritic cells augments the antitumor reactivity of tumor-primed lymph node cells.
    Li Q; Grover AC; Donald EJ; Carr A; Yu J; Whitfield J; Nelson M; Takeshita N; Chang AE
    J Immunol; 2005 Aug; 175(3):1424-32. PubMed ID: 16034078
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow.
    Jin Y; Fuller L; Ciancio G; Burke GW; Tzakis AG; Ricordi C; Miller J; Esquenzai V
    Hum Immunol; 2004 Feb; 65(2):93-103. PubMed ID: 14969764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Functional expression of CD80 and CD86 allows immunogenicity of malignant B cells from non-Hodgkin's lymphomas.
    Chaperot L; Plumas J; Jacob MC; Bost F; Molens JP; Sotto JJ; Bensa JC
    Exp Hematol; 1999 Mar; 27(3):479-88. PubMed ID: 10089910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD40-induced aggregation of MHC class II and CD80 on the cell surface leads to an early enhancement in antigen presentation.
    Clatza A; Bonifaz LC; Vignali DA; Moreno J
    J Immunol; 2003 Dec; 171(12):6478-87. PubMed ID: 14662847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B lymphocytes can be activated to act as antigen presenting cells to promote anti-tumor responses.
    Rossetti RAM; Lorenzi NPC; Yokochi K; Rosa MBSF; Benevides L; Margarido PFR; Baracat EC; Carvalho JP; Villa LL; Lepique AP
    PLoS One; 2018; 13(7):e0199034. PubMed ID: 29975708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of Friend Virus Infection and Regulatory T Cells on the Antigen Presentation Function of B Cells.
    Moore TC; Messer RJ; Gonzaga LM; Mather JM; Carmody AB; Bayer W; Littwitz-Salomon E; Dittmer U; Hasenkrug KJ
    mBio; 2019 Jan; 10(1):. PubMed ID: 30670616
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD40 activation of BCP-ALL cells generates IL-10-producing, IL-12-defective APCs that induce allogeneic T-cell anergy.
    D'Amico G; Vulcano M; Bugarin C; Bianchi G; Pirovano G; Bonamino M; Marin V; Allavena P; Biagi E; Biondi A
    Blood; 2004 Aug; 104(3):744-51. PubMed ID: 15001471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human dendritic cells skew isotype switching of CD40-activated naive B cells towards IgA1 and IgA2.
    Fayette J; Dubois B; Vandenabeele S; Bridon JM; Vanbervliet B; Durand I; Banchereau J; Caux C; Brière F
    J Exp Med; 1997 Jun; 185(11):1909-18. PubMed ID: 9166420
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The properties of human CD40-activated B cells as antigen-presenting cells are not affected by PGE2.
    Shimabukuro-Vornhagen A; Draube A; Liebig T; Popov A; Rothe A; von Bergwelt-Baildon M
    Oncol Rep; 2013 Mar; 29(3):1061-5. PubMed ID: 23292511
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Autogeneic rna-electroporated CD40-ligand activated b-cells from hepatocellular carcinoma patients induce CD8+ T-cell responses ex vivo.
    Shen S; Xu Z; Qian X; Ding Y; Yu L; Liu B
    Exp Oncol; 2007 Jun; 29(2):137-43. PubMed ID: 17704747
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activation of human B cells by the agonist CD40 antibody CP-870,893 and augmentation with simultaneous toll-like receptor 9 stimulation.
    Carpenter EL; Mick R; Rüter J; Vonderheide RH
    J Transl Med; 2009 Nov; 7():93. PubMed ID: 19906293
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Generation of human CD40-activated B cells.
    Liebig TM; Fiedler A; Zoghi S; Shimabukuro-Vornhagen A; von Bergwelt-Baildon MS
    J Vis Exp; 2009 Oct; (32):. PubMed ID: 19838159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CD40-activated B-cell chronic lymphocytic leukemia cells for tumor immunotherapy: stimulation of allogeneic versus autologous T cells generates different types of effector cells.
    Buhmann R; Nolte A; Westhaus D; Emmerich B; Hallek M
    Blood; 1999 Mar; 93(6):1992-2002. PubMed ID: 10068672
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sequential delivery of maturation stimuli increases human dendritic cell IL-12 production and enhances tumor antigen-specific immunogenicity.
    Kalady MF; Onaitis MW; Emani S; Abdel-Wahab Z; Tyler DS; Pruitt SK
    J Surg Res; 2004 Jan; 116(1):24-31. PubMed ID: 14732346
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activated B cells modified by electroporation of multiple mRNAs encoding immune stimulatory molecules are comparable to mature dendritic cells in inducing in vitro antigen-specific T-cell responses.
    Lee J; Dollins CM; Boczkowski D; Sullenger BA; Nair S
    Immunology; 2008 Oct; 125(2):229-40. PubMed ID: 18393968
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glucocorticoids transform CD40-triggering of dendritic cells into an alternative activation pathway resulting in antigen-presenting cells that secrete IL-10.
    Rea D; van Kooten C; van Meijgaarden KE; Ottenhoff TH; Melief CJ; Offringa R
    Blood; 2000 May; 95(10):3162-7. PubMed ID: 10807783
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A membrane-bound form of IL-4 enhances proliferation and antigen presentation of CD40-activated human B cells.
    Park JY; Yoon SH; Kim EK; Yun SO; Park MY; Sohn HJ; Kim TG
    Immunol Lett; 2008 Feb; 116(1):33-40. PubMed ID: 18096249
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.